- Home
- APLM vs ZEO Comparison
APLM vs ZEO Comparison
Compare APLM & ZEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLM
- ZEO
- Stock Information
- Founded
- APLM 2016
- ZEO 2005
- Country
- APLM United States
- ZEO United States
- Employees
- APLM N/A
- ZEO N/A
- Industry
- APLM Blank Checks
- ZEO
- Sector
- APLM Finance
- ZEO
- Exchange
- APLM Nasdaq
- ZEO NYSE
- Market Cap
- APLM 15.6M
- ZEO 25.7M
- IPO Year
- APLM N/A
- ZEO N/A
- Fundamental
- Price
- APLM $9.75
- ZEO $2.04
- Analyst Decision
- APLM Strong Buy
- ZEO
- Analyst Count
- APLM 2
- ZEO 0
- Target Price
- APLM $425.00
- ZEO N/A
- AVG Volume (30 Days)
- APLM 102.2K
- ZEO 2.7M
- Earning Date
- APLM 02-15-2025
- ZEO 12-31-2024
- Dividend Yield
- APLM N/A
- ZEO N/A
- EPS Growth
- APLM N/A
- ZEO N/A
- EPS
- APLM N/A
- ZEO 0.67
- Revenue
- APLM $2,101,000.00
- ZEO $95,455,763.00
- Revenue This Year
- APLM N/A
- ZEO N/A
- Revenue Next Year
- APLM N/A
- ZEO N/A
- P/E Ratio
- APLM N/A
- ZEO $2.28
- Revenue Growth
- APLM 70.54
- ZEO N/A
- 52 Week Low
- APLM $6.50
- ZEO $1.05
- 52 Week High
- APLM $105.00
- ZEO $11.60
- Technical
- Relative Strength Index (RSI)
- APLM 50.39
- ZEO 54.35
- Support Level
- APLM $7.23
- ZEO $1.50
- Resistance Level
- APLM $8.88
- ZEO $3.05
- Average True Range (ATR)
- APLM 1.37
- ZEO 0.51
- MACD
- APLM 0.21
- ZEO -0.03
- Stochastic Oscillator
- APLM 57.91
- ZEO 43.26
About APLM Apollomics Inc.
Apollomics Inc is an innovative clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company lead programs include vebreltinib (APL-101), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other advanced tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia.
About ZEO ZEO ENERGY CORP
Zeo Energy Corp is a vertically integrated provider of residential solar energy systems, other energy efficient equipment and related services currently serving customers in Florida, Texas, Arkansas, and Missouri. Its primary business activity is selling and installing residential solar energy systems that homeowners use to supplement the amount of usable electricity required to power their homes.